Literature DB >> 27888818

High altitude illness

Anna Hartman-Ksycińska1, Jolanta Kluz-Zawadzka2, Bogumił Lewandowski3.   

Abstract

High-altitude illness is a result of prolonged high-altitude exposure of unacclimatized individuals. The illness is seen in the form of acute mountain sickness (AMS) which if not treated leads to potentially life-threatening high altitude pulmonary oedema and high-altitude cerebral oedema. Medical problems are caused by hypobaric hypoxia stimulating hypoxia-inducible factor (HIF) release. As a result, the central nervous system, circulation and respiratory system function impairment occurs. The most important factor in AMS treatment is acclimatization, withdrawing further ascent and rest or beginning to descent; oxygen supplementation, and pharmacological intervention, and, if available, a portable hyperbaric chamber. Because of the popularity of high-mountain sports and tourism better education of the population at risk is essential.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27888818

Source DB:  PubMed          Journal:  Przegl Epidemiol        ISSN: 0033-2100


  9 in total

1.  Deletion of the fih gene encoding an inhibitor of hypoxia-inducible factors increases hypoxia tolerance in zebrafish.

Authors:  Xiaolian Cai; Dawei Zhang; Jing Wang; Xing Liu; Gang Ouyang; Wuhan Xiao
Journal:  J Biol Chem       Date:  2018-08-20       Impact factor: 5.157

Review 2.  High altitude exposure affects male reproductive parameters: could it also affect the prostate?†.

Authors:  Diana Elizabeth Alcantara-Zapata; Aníbal J Llanos; Carolina Nazzal
Journal:  Biol Reprod       Date:  2022-03-19       Impact factor: 4.285

3.  EPAS1 and VEGFA gene variants are related to the symptoms of acute mountain sickness in Chinese Han population: a cross-sectional study.

Authors:  Ji-Hang Zhang; Yang Shen; Chuan Liu; Jie Yang; Yuan-Qi Yang; Chen Zhang; Shi-Zhu Bian; Jie Yu; Xu-Bin Gao; Lai-Ping Zhang; Jing-Bin Ke; Fang-Zheng-Yuan Yuan; Wen-Xu Pan; Zhi-Nian Guo; Lan Huang
Journal:  Mil Med Res       Date:  2020-07-27

4.  ALS blood expression profiling identifies new biomarkers, patient subgroups, and evidence for neutrophilia and hypoxia.

Authors:  William R Swindell; Colin P S Kruse; Edward O List; Darlene E Berryman; John J Kopchick
Journal:  J Transl Med       Date:  2019-05-22       Impact factor: 5.531

5.  Angiotensin-converting enzyme gene insertion/deletion polymorphism and high-altitude pulmonary edema: An updated meta-analysis.

Authors:  Yan Zheng; Jin Huang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Jan-Mar       Impact factor: 1.636

6.  Application of 7.0 T ultra-high-field MRI in evaluating the structure and function of the right ventricle of the heart in rats under a chronic hypoxic environment at high altitude.

Authors:  Yanqiu Sun; Chenhong Zhang; Dengfeng Tian; Junhu Bai; Yaodong Li; Xiaosheng Yu; Jing Yang; Xueling Wang; Yongxing Dong; Mei Yang; Zhiqiang Kang; Qiang Zhang; Fabao Gao
Journal:  Ann Transl Med       Date:  2021-10

7.  Anterior Circulation Acute Ischemic Stroke in the Plateau of China: Risk Factors and Clinical Characteristics.

Authors:  Yujia Yan; Xiqiang Zhang; Hecheng Ren; Xingwei An; Wanpeng Fan; Jingbo Liang; Ying Huang
Journal:  Front Neurol       Date:  2022-04-13       Impact factor: 4.003

8.  High Altitude Cerebral Edema: Improving Treatment Options.

Authors:  Rebecca Zelmanovich; Kevin Pierre; Patrick Felisma; Dwayne Cole; Matthew Goldman; Brandon Lucke-Wold
Journal:  Biologics (Basel)       Date:  2022-03-17

9.  [Betelnut polyphenols provide protection against high-altitude hypoxia in rats].

Authors:  Y Huo; A Zhao; J Song; J Li; R Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-05-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.